Khuntirat B, Love C, Buddhari D, Heil G, Gibbons R, Rothman A, et al. Absence of neutralizing antibodies against influenza A/H5N1 virus among children in Kamphaeng Phet, Thailand. J Clin Virol. 2015;69:78-80 pubmed publisher

Sun X, Belser J, Pappas C, Pulit Penaloza J, Brock N, Zeng H, et al. Risk Assessment of Fifth-Wave H7N9 Influenza A Viruses in Mammalian Models. J Virol. 2019;93: pubmed publisher

Mar K, Rinkenberger N, Boys I, Eitson J, McDougal M, Richardson R, et al. LY6E mediates an evolutionarily conserved enhancement of virus infection by targeting a late entry step. Nat Commun. 2018;9:3603 pubmed publisher

Pulit Penaloza J, Pappas C, Belser J, Sun X, Brock N, Zeng H, et al. Comparative In Vitro and In Vivo Analysis of H1N1 and H1N2 Variant Influenza Viruses Isolated from Humans between 2011 and 2016. J Virol. 2018;92: pubmed publisher

Sun X, Pulit Penaloza J, Belser J, Pappas C, Pearce M, Brock N, et al. Pathogenesis and Transmission of Genetically Diverse Swine-Origin H3N2 Variant Influenza A Viruses from Multiple Lineages Isolated in the United States, 2011-2016. J Virol. 2018;92: pubmed publisher

Raymond D, Bajic G, Ferdman J, Suphaphiphat P, Settembre E, Moody M, et al. Conserved epitope on influenza-virus hemagglutinin head defined by a vaccine-induced antibody. Proc Natl Acad Sci U S A. 2018;115:168-173 pubmed publisher

Lee N, Le Sage V, Nanni A, Snyder D, Cooper V, Lakdawala S. Genome-wide analysis of influenza viral RNA and nucleoprotein association. Nucleic Acids Res. 2017;45:8968-8977 pubmed publisher

Belser J, Pulit Penaloza J, Sun X, Brock N, Pappas C, Creager H, et al. A Novel A(H7N2) Influenza Virus Isolated from a Veterinarian Caring for Cats in a New York City Animal Shelter Causes Mild Disease and Transmits Poorly in the Ferret Model. J Virol. 2017;91: pubmed publisher

Tung C, Chen I, Yu C, Peng H, Jian J, Ma S, et al. Discovering neutralizing antibodies targeting the stem epitope of H1N1 influenza hemagglutinin with synthetic phage-displayed antibody libraries. Sci Rep. 2015;5:15053 pubmed publisher

Wang J, Peng Y, Zhao L, Cao M, Hung T, Deng T. Influenza A virus utilizes a suboptimal Kozak sequence to fine-tune virus replication and host response. J Gen Virol. 2015;96:756-66 pubmed publisher

Sanpui P, Zheng X, Loeb J, Bisesi J, Khan I, Afrooz A, et al. Single-walled carbon nanotubes increase pandemic influenza A H1N1 virus infectivity of lung epithelial cells. Part Fibre Toxicol. 2014;11:66 pubmed publisher

Cao M, Wei C, Zhao L, Wang J, Jia Q, Wang X, et al. DnaJA1/Hsp40 is co-opted by influenza A virus to enhance its viral RNA polymerase activity. J Virol. 2014;88:14078-89 pubmed publisher

Si Y, Li J, Niu Y, Liu X, Ren L, Guo L, et al. Entry properties and entry inhibitors of a human H7N9 influenza virus. PLoS ONE. 2014;9:e107235 pubmed publisher

Jia R, Xu F, Qian J, Yao Y, Miao C, Zheng Y, et al. Identification of an endocytic signal essential for the antiviral action of IFITM3. Cell Microbiol. 2014;16:1080-93 pubmed publisher

Terletskaia Ladwig E, Meier S, Enders M. Improved high-throughput virus neutralisation assay for antibody estimation against pandemic and seasonal influenza strains from 2009 to 2011. J Virol Methods. 2013;189:341-7 pubmed publisher

Plourde J, Pyles J, Layton R, Vaughan S, Tipper J, Harrod K. Neurovirulence of H5N1 infection in ferrets is mediated by multifocal replication in distinct permissive neuronal cell regions. PLoS ONE. 2012;7:e46605 pubmed publisher

Schmidt T, Dirks J, Enders M, Gärtner B, Uhlmann Schiffler H, Sester U, et al. CD4+ T-cell immunity after pandemic influenza vaccination cross-reacts with seasonal antigens and functionally differs from active influenza infection. Eur J Immunol. 2012;42:1755-66 pubmed publisher

Macinnes H, Zhou Y, Gouveia K, Cromwell J, Lowery K, Layton R, et al. Transmission of aerosolized seasonal H1N1 influenza A to ferrets. PLoS ONE. 2011;6:e24448 pubmed publisher

Gubareva L, Trujillo A, Okomo Adhiambo M, Mishin V, Deyde V, Sleeman K, et al. Comprehensive assessment of 2009 pandemic influenza A (H1N1) virus drug susceptibility in vitro. Antivir Ther. 2010;15:1151-9 pubmed publisher

Mitchell H, Levin D, Forrest S, Beauchemin C, Tipper J, Knight J, et al. Higher level of replication efficiency of 2009 (H1N1) pandemic influenza virus than those of seasonal and avian strains: kinetics from epithelial cell culture and computational modeling. J Virol. 2011;85:1125-35 pubmed publisher

McCullers J, Van De Velde L, Allison K, Branum K, Webby R, Flynn P. Recipients of vaccine against the 1976 "swine flu" have enhanced neutralization responses to the 2009 novel H1N1 influenza virus. Clin Infect Dis. 2010;50:1487-92 pubmed publisher

Lednicky J, Villanueva J, Burke S, Shively R, Shaw M, Daniels D, et al. Validation of a method for preparing influenza H5N1 simulated samples. J Virol Methods. 2010;167:125-31 pubmed publisher

Antarasena C, Sirimujalin R, Prommuang P, Promkuntod N, Prommuang P, Blacksell S. The indirect immunofluorescence assay using cardiac tissue from chickens, quails and ducks for identification of influenza A virus during an outbreak of highly pathogenic avian influenza virus (H5N1): a rapid and simple screening tool for limited res. Res Vet Sci. 2007;83:279-81 pubmed

Antarasena C, Sirimujalin R, Prommuang P, Blacksell S, Promkuntod N, Prommuang P. Tissue tropism of a Thailand strain of high-pathogenicity avian influenza virus (H5N1) in tissues of naturally infected native chickens (Gallus gallus), Japanese quail (Coturnix coturnix japonica) and ducks (Anas spp.). Avian Pathol. 2006;35:250-3 pubmed